# A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection

> **NCT05137717** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 41 (actual)

## Conditions studied

- Cytomegalovirus (CMV)

## Interventions

- **DRUG:** Maribavir

## Key facts

- **NCT ID:** NCT05137717
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-18
- **Primary completion:** 2023-06-27
- **Final completion:** 2023-06-27
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137717, "A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05137717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*